Bradmer Pharmaceuticals Inc.
Profile
Mailing Address: c/o Wildeboer Dellelce LLP
1 First Canadian Place, Suite 810
Toronto, Ontario
M5X 1A9
Head Office Address: c/o Wildeboer Dellelce LLP
1 First Canadian Place, Suite 810
Toronto, Ontario
M5X 1A9
Contact Name: Dr. Mark C. Rogers Principal Regulator: Ontario
Business e-mail address: Short Form Prospectus Issuer: No
Telephone Number: 416 361-3121 Reporting Jurisdictions: Ceased Reporting
Fax Number: 416 361-1790 Stock Exchange: N/A
Date of Formation: Jun 16 2005 Stock Symbol:
Jurisdiction Where Formed: Ontario Auditor: DMCT, LLP
Industry Classification: other General Partner:
CUSIP Number: 10463R Transfer Agent: Equity Transfer Services Inc.
Financial Year-End: Dec 31 Size of Issuer (Assets): Under $5,000,000


This company is a previous issuer to   Bradmer Pharmaceuticals Inc.
View This Company's Documents